{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:08Z","timestamp":1740126428008,"version":"3.37.3"},"reference-count":3,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,27]]},"abstract":"<jats:p>This article details three cases of solid-organ malignancy associated with TNF-alpha inhibitor therapy for hidradenitis suppurativa. It highlights the unknown effect of biologic agents on cancer risk in these patients, who have a baseline elevated cancer risk.<\/jats:p>","DOI":"10.1093\/ced\/llad030","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T01:47:24Z","timestamp":1674784044000},"page":"553-554","source":"Crossref","is-referenced-by-count":1,"title":["Solid-organ malignancy in patients with hidradenitis suppurativa treated with tumour necrosis factor-alpha inhibitors: a case series"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0026-9117","authenticated-orcid":false,"given":"Fiona","family":"Lynch","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospital Limerick , Co. Limerick , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary-Catherine","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Limerick , Co. Limerick , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Sadlier","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Limerick , Co. Limerick , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"2023100416452080500_llad030-B1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2019.06.016","article-title":"All-cause mortality among patients with hidradenitis suppurativa: a population-based cohort study in the United States","volume":"81","author":"Reddy","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023100416452080500_llad030-B2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jamadermatol.2020.1422","article-title":"Assessment of overall and specific cancer risks in patients with hidradenitis suppurativa","volume":"156","author":"Jung","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2023100416452080500_llad030-B3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/ced.14264","article-title":"Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa","volume":"45","author":"Frew","year":"2020","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad030\/49297878\/llad030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/5\/553\/51854868\/llad030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/5\/553\/51854868\/llad030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T16:45:41Z","timestamp":1696437941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/5\/553\/7005259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":3,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,1,25]]},"published-print":{"date-parts":[[2023,4,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad030","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,1,25]]}}}